Kate Rochlin

Company: IN8Bio

Job title: Chief Operating Officer

Seminars:

Case Study: Clinical Gamma-Delta T-Cell Therapies, Demonstrating Persistence & Durability for Positive Outcomes in Hematological & Solid Tumours 12:00 pm

The first clinical data on gamma-delta T-cell therapies demonstrating persistence, durability and expansion in patients Leveraging gamma-delta T-cell properties to evade the endogenous immune response Intelligent engineering to maximise the tumor targeting ability of gamma-delta T-cells to bring cell therapies into solid tumoursRead more

day: Conference Day One